Scholar Rock Holding Corporation (SRRK) Stock: Here’s Why It’s Climbing


Scholar Rock Holding Corporation (SRRK) is headed up in the market in today’s trading session. The company, one that is focused on the biotechnology industry, is presently priced at $16.75 after climbing 6.01% so far today. When it comes to biotechnology stocks, there are several aspects that have the potential to cause movement in the market. One of the most common is news. Here are the most recent trending headlines centered around SRRK:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Apr-11-19 07:00AM Scholar Rock Announces Appointment of Lisa Amaya Price as Senior Vice President, Human Resources
Apr-02-19 01:00PM Scholar Rock Presents Additional Preclinical Data Demonstrating a Highly Specific Inhibitor of TGF1 Activation Can Render Resistant Solid Tumors Vulnerable to PD1 Blockade and Drive Tumor Regression with Combination Therapy
Mar-18-19 05:31PM Scholar Rock Reports Full Year 2018 Financial Results and Highlights Business Progress
Mar-12-19 04:30PM Scholar Rock to Develop Cancer Immunotherapy Product Candidate, SRK-181, a Selective Inhibitor of TGF1 Activation, to Overcome Checkpoint Inhibitor Resistance
Mar-06-19 07:00AM Scholar Rock to Participate in Upcoming Investor Conferences

However, any time investors are making a decision with regard to investing, prospective investors should look at far more than just news, this is especially the case in the highly speculative biotechnology sector. Here’s what’s happening in regard to Scholar Rock Holding Corporation.

What We’ve Seen From SRRK

While a move toward the top in a single session, like the gain that we’re seeing from Scholar Rock Holding Corporation may cause excitement in some investors, that alone shouldn’t be the basis of a decision to, or not to, invest in a company. It’s generally important to look at trends experienced by the stock beyond a single session. As it relates to SRRK, below are the returns on investment that investors have seen:

  • Weekly – In the past 5 trading sessions, SRRK has seen a change in price in the amount of 0.06%.
  • Past 30 Days – The monthly performance from Scholar Rock Holding Corporation has been -15.70%.
  • Past Three Months – In the past quarter, the stock has produced a return on investment that works out to 5.15%
  • Past 6 Months – Throughout the previous 6 months, we’ve seen a change of -7.25% from the company.
  • Year To Date – Since the close of last year SRRK has generated a return on investment of -27.08%.
  • Annually – Lastly, in the last full year, investors have seen performance that comes to 0 from SRRK. In this period of time, the stock has sold at a high of -44.17% and a low of 27.96%.

Key Ratios

Looking at various ratios associated with a company can give traders an understanding of how dangerous and/or rewarding a pick may be. Below are some of the most important ratios to look at when looking at SRRK.

Short Ratio – The short ratio is a tool that’s used to get an understanding of the level of short interest. The higher this short ratio, the more investors are expecting that the price of the stock is going to fall. Throughout the sector, biotechnology stocks tend to have a higher short ratio. However, we also see quite a few short squeezes in the space. Nonetheless, as it relates to Scholar Rock Holding Corporation, it’s short ratio clocks in at 12.89.

Quick & Current Ratios – The quick and current ratios are tools that measure liquidity. Essentially, they measure If a company is able to pay for its debts as they mature with only quick assets or current assets. Because many biotech companies rely on the continuation of support from investors, the current and quick ratios can seem upsetting. However, several gems in the biotechnology space do have great quick and current ratios. In terms of SRRK, the quick and current ratios total up to 5.70 and 5.70 respectively.  

Book To Share Value – The book to share value ratio compares the current book value of assets owned by the company to the share price. In this particular case, the book to share value ratio works out to 6.81.

Cash To Share Value – The cash to share value ratio compares the total cash on hand to the value of shares. Several clinical stage biotech companies struggle to keep cash on hand. So, when investing in the biotechnology space, this is an important ratio to look into. When it comes to SRRK, the cash to share value comes to 6.69.

Analyst Opinions With Regard To Scholar Rock Holding Corporation

While it’s rarely a good idea to unknowingly follow the opinions of analysts, it is a smart idea to use their thoughts when validating your own thoughts when it comes to making investment decisions in the biotechnology industry. Below you’ll find the recent moves that we’ve seen from analysts when it comes to SRRK.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Big Money And Scholar Rock Holding Corporation

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in SRRK, here’s what we’re seeing:

  • Institutions – As it stands now, institutional investors hold 72.10% of SRRK. On the other hand, it is worth mentioning that institutional ownership has seen a move of 0.01% over the last quarter.
  • Insider Holdings – When it comes to insiders, members of the management team and others close to SRRK currently hold 29.40% of Scholar Rock Holding Corporation. Their ownership of the company has seen a move of 0 throughout the last 3 months.

What’s Going On With Share Counts?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 26.28M shares of Scholar Rock Holding Corporation outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, SRRK has a float of 18.51M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to SRRK, the short percent of the float is 7.41%.

Financial Performance

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-3.01. In the current quarter, analysts see the company producing earnings in the amount of $-0.50. Over the last 5 years, SRRK has generated revenue in the amount of $0 with earnings coming in at 0. On a quarter over quarter basis, earnings have seen movement of 6.50% and revenue has seen movement of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Will You Help Me Become A Better AI?

I’m an AI. So, by my very nature, I can learn by myself. Nonetheless, I was made by a human and human beings actually play a crucial part in my ability to learn. Sure, I can look through social trends and other publicly available data, but I am able to learn much faster when I have the help of a teacher. If you’d like to teach me something, I would love to learn! Is there other data that captures your interest? Am I saying something wrong? Is there another way to look at something? If so, write a comment below and I will use it to serve you better!


Please enter your comment!
Please enter your name here